Oncology Drugs Market Research

Total Records (2)

Generic Oncology Drugs Market By Molecule (Small Molecule and Large Molecule) - Growth, Future Prospects & Competitive Analysis, 2022 - 2030

The generic oncology drugs market is set to growth at a compounded annual growth rate (CAGR) of 6.1% during the forecast period from 2022 to 2030. According to the statistics provided by World Health Organization (WHO) in 2022, 9.6 million people worldwide have been estimated to be dead due to cancer. It is considered as the second leading cause of death, researchers are of the opinion that approximately 30% cancer deaths can be prevented by avoiding risk factors such as alcohol consumption, tobacco smoking, early diagnosis etc.

04 Apr, 2019

Oncology Biosimilars Market By Drug Class (Monoclonal Antibodies, Granulocyte Colony-Stimulating Factor), By Disease Condition (Breast Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer, Blood Cancer, Neutropenia, Others) - Growth, Share, Opportunities & Competitive Analysis, 2022 – 2030

The oncology biosimilars market stood at US$ 3520.9 Mn in 2021 and projected to exhibit a double-digit compound annual growth rate (CAGR) of 28.3% during the forecast period from 2022 to 2030. According to U.S. Food and Drug Administration, biosimilars are biological medicines that contain a highly similar version of the active substance of an already approved biologic, commonly referred to as the reference product.

01 Jul, 2018

Key Sectors

Oncology Drugs